Cargando…

The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease

In sickle cell disease (SCD), heme released during intravascular hemolysis promotes oxidative stress, inflammation, and vaso-occlusion. Conversely, free heme can also activate expression of antioxidant and globin genes. Heme binds to the transcription factor BACH1, which represses NRF2-mediated gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Belcher, John D., Nataraja, Selvaraj, Abdulla, Fuad, Zhang, Ping, Chen, Chunsheng, Nguyen, Julia, Ruan, Conglin, Singh, Maneet, Demes, Shilpa, Olson, Lyndsay, Stickens, Domi, Stanwix, Jeff, Clarke, Emer, Huang, Yongzhao, Biddle, Margaret, Vercellotti, Gregory M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152901/
https://www.ncbi.nlm.nih.gov/pubmed/37144034
http://dx.doi.org/10.3389/fmed.2023.1101501
_version_ 1785035828343341056
author Belcher, John D.
Nataraja, Selvaraj
Abdulla, Fuad
Zhang, Ping
Chen, Chunsheng
Nguyen, Julia
Ruan, Conglin
Singh, Maneet
Demes, Shilpa
Olson, Lyndsay
Stickens, Domi
Stanwix, Jeff
Clarke, Emer
Huang, Yongzhao
Biddle, Margaret
Vercellotti, Gregory M.
author_facet Belcher, John D.
Nataraja, Selvaraj
Abdulla, Fuad
Zhang, Ping
Chen, Chunsheng
Nguyen, Julia
Ruan, Conglin
Singh, Maneet
Demes, Shilpa
Olson, Lyndsay
Stickens, Domi
Stanwix, Jeff
Clarke, Emer
Huang, Yongzhao
Biddle, Margaret
Vercellotti, Gregory M.
author_sort Belcher, John D.
collection PubMed
description In sickle cell disease (SCD), heme released during intravascular hemolysis promotes oxidative stress, inflammation, and vaso-occlusion. Conversely, free heme can also activate expression of antioxidant and globin genes. Heme binds to the transcription factor BACH1, which represses NRF2-mediated gene transcription. ASP8731, is a selective small molecule inhibitor of BACH1. We investigated the ability of ASP8731 to modulate pathways involved in SCD pathophysiology. In HepG2 liver cells, ASP8731 increased HMOX1 and FTH1 mRNA. In pulmonary endothelial cells, ASP8731 decreased VCAM1 mRNA in response to TNF-α and blocked a decrease in glutathione in response to hemin. Townes-SS mice were gavaged once per day for 4 weeks with ASP8731, hydroxyurea (HU) or vehicle. Both ASP8731 and HU inhibited heme-mediated microvascular stasis and in combination, ASP8731 significantly reduced microvascular stasis compared to HU alone. In Townes-SS mice, ASP8731 and HU markedly increased heme oxygenase-1 and decreased hepatic ICAM-1, NF-kB phospho-p65 protein expression in the liver, and white blood cell counts. In addition, ASP8731 increased gamma-globin expression and HbF+ cells (F-cells) as compared to vehicle-treated mice. In human erythroid differentiated CD34+ cells, ASP8731 increased HGB mRNA and increased the percentage of F-cells 2-fold in manner similar to HU. ASP8731 and HU when given together induced more HbF+ cells compared to either drug alone. In CD34+ cells from one donor that was non-responsive to HU, ASP8731 induced HbF+ cells ~2-fold. ASP8731 and HU also increased HBG and HBA, but not HBB mRNA in erythroid differentiated CD34+ cells derived from SCD patients. These data indicate that BACH1 may offer a new therapeutic target to treat SCD.
format Online
Article
Text
id pubmed-10152901
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101529012023-05-03 The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease Belcher, John D. Nataraja, Selvaraj Abdulla, Fuad Zhang, Ping Chen, Chunsheng Nguyen, Julia Ruan, Conglin Singh, Maneet Demes, Shilpa Olson, Lyndsay Stickens, Domi Stanwix, Jeff Clarke, Emer Huang, Yongzhao Biddle, Margaret Vercellotti, Gregory M. Front Med (Lausanne) Medicine In sickle cell disease (SCD), heme released during intravascular hemolysis promotes oxidative stress, inflammation, and vaso-occlusion. Conversely, free heme can also activate expression of antioxidant and globin genes. Heme binds to the transcription factor BACH1, which represses NRF2-mediated gene transcription. ASP8731, is a selective small molecule inhibitor of BACH1. We investigated the ability of ASP8731 to modulate pathways involved in SCD pathophysiology. In HepG2 liver cells, ASP8731 increased HMOX1 and FTH1 mRNA. In pulmonary endothelial cells, ASP8731 decreased VCAM1 mRNA in response to TNF-α and blocked a decrease in glutathione in response to hemin. Townes-SS mice were gavaged once per day for 4 weeks with ASP8731, hydroxyurea (HU) or vehicle. Both ASP8731 and HU inhibited heme-mediated microvascular stasis and in combination, ASP8731 significantly reduced microvascular stasis compared to HU alone. In Townes-SS mice, ASP8731 and HU markedly increased heme oxygenase-1 and decreased hepatic ICAM-1, NF-kB phospho-p65 protein expression in the liver, and white blood cell counts. In addition, ASP8731 increased gamma-globin expression and HbF+ cells (F-cells) as compared to vehicle-treated mice. In human erythroid differentiated CD34+ cells, ASP8731 increased HGB mRNA and increased the percentage of F-cells 2-fold in manner similar to HU. ASP8731 and HU when given together induced more HbF+ cells compared to either drug alone. In CD34+ cells from one donor that was non-responsive to HU, ASP8731 induced HbF+ cells ~2-fold. ASP8731 and HU also increased HBG and HBA, but not HBB mRNA in erythroid differentiated CD34+ cells derived from SCD patients. These data indicate that BACH1 may offer a new therapeutic target to treat SCD. Frontiers Media S.A. 2023-04-18 /pmc/articles/PMC10152901/ /pubmed/37144034 http://dx.doi.org/10.3389/fmed.2023.1101501 Text en Copyright © 2023 Belcher, Nataraja, Abdulla, Zhang, Chen, Nguyen, Ruan, Singh, Demes, Olson, Stickens, Stanwix, Clark, Huang, Biddle and Vercellotti. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Belcher, John D.
Nataraja, Selvaraj
Abdulla, Fuad
Zhang, Ping
Chen, Chunsheng
Nguyen, Julia
Ruan, Conglin
Singh, Maneet
Demes, Shilpa
Olson, Lyndsay
Stickens, Domi
Stanwix, Jeff
Clarke, Emer
Huang, Yongzhao
Biddle, Margaret
Vercellotti, Gregory M.
The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
title The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
title_full The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
title_fullStr The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
title_full_unstemmed The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
title_short The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
title_sort bach1 inhibitor asp8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152901/
https://www.ncbi.nlm.nih.gov/pubmed/37144034
http://dx.doi.org/10.3389/fmed.2023.1101501
work_keys_str_mv AT belcherjohnd thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT natarajaselvaraj thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT abdullafuad thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT zhangping thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT chenchunsheng thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT nguyenjulia thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT ruanconglin thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT singhmaneet thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT demesshilpa thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT olsonlyndsay thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT stickensdomi thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT stanwixjeff thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT clarkeemer thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT huangyongzhao thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT biddlemargaret thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT vercellottigregorym thebach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT belcherjohnd bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT natarajaselvaraj bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT abdullafuad bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT zhangping bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT chenchunsheng bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT nguyenjulia bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT ruanconglin bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT singhmaneet bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT demesshilpa bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT olsonlyndsay bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT stickensdomi bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT stanwixjeff bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT clarkeemer bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT huangyongzhao bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT biddlemargaret bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease
AT vercellottigregorym bach1inhibitorasp8731inhibitsinflammationandvasoocclusionandinducesfetalhemoglobininsicklecelldisease